Serum Levels of Thioredoxin Are Associated with Stroke Risk, Severity, and Lesion Volumes

Molecular Neurobiology

Volumn 53, Issue 1, 2016, Pages 677-685

  Wu, Meng Hai ^a   Song, Fang Yu ^a   Wei, Li Ping ^a   Meng, Zhao Yun ^a   Zhang, Zhi Qiang ^a   Qi, Qin De ^a  

^a Laiwu People s Hospital   (China)

Author keywords

Acute ischemic stroke; Chinese; Oxidative stress; Risk; Thioredoxin

Indexed keywords

THIOREDOXIN; BIOLOGICAL MARKER;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN DAMAGE; BRAIN ISCHEMIA; CHINESE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STROKE PATIENT; BLOOD; MIDDLE AGED; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STROKE;

AGED; BIOMARKERS; BRAIN ISCHEMIA; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE; THIOREDOXINS;

EID: 84953359220     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-014-9016-y     Document Type: Article

References (48)

1. Zhang ZG, Wang C, Wang J, Zhang Z, Yang YL, Gao L, Zhang XY, Chang T, Gao GD, Li LH (2014) Prognostic value of mannose-binding lectin: 90-day outcome in patients with acute ischemic stroke. Mol Neurobiol. doi:10.1007/s12035-014-8682-0
2. Allen CL, Bayraktutan U (2009) Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke 4(6):461–470
3. Liu L, Wang D, Wong KS, Wang Y (2011) Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke 42(12):3651–3654
4. Li SY, Gao Y, Ma WN et al (2014) The relationship between serum lipoprotein (a) levels and ischemic stroke risk: a cohort study in the Chinese population. Inflammation 37:686–693
5. Alexandrova ML, Bochev PG (2005) Oxidative stress during the chronic phase after stroke. Free Radic Biol Med 39(3):297–316
6. Chauhan A, Chauhan V (2006) Oxidative stress in autism. Pathophysiology 13:171–181
7. Söğüt S, Zoroğlu SS, Özyurt H et al (2003) Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. Clin Chim Acta 331(1):111–117
8. Cherubini A, Ruggiero C, Polidori MC et al (2005) Potential markers of oxidative stress in stroke. Free Radic Biol Med 39(7):841–852
9. Danton GH, Dietrich WD (2003) Inflammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol 62(2):127–136
10. Drake C, Boutin H, Jones MS et al (2011) Brain inflammation is induced by co-morbidities and risk factors for stroke. Brain Behav Immun 25(6):1113–1122
11. Jikimoto T, Nishikubo Y, Koshiba M et al (2002) Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis. Mol Immunol 38(10):765–772
12. Nakamura H, De Rosa S, Roederer M, Anderson MT, Dubs JG, Yodoi J, Holmgren A, Herzenberg LA, Herzenberg LA (1996) Elevation of plasma thioredoxin levels in HIV-infected individuals. Int Immunol 8:603–611
13. Taniguchi Y, Taniguchi-Ueda Y, Mori K, Yodoi J (1996) A novel promoter sequence is involved in the oxidative stress-induced expression of the adult T-cell leukemia-derived factor (ADF)/human thioredoxin (TRX) gene. Nucl Acids Res 24:2746–2752
14. Nakamura H (2005) Thioredoxin and its related molecules: update 2005. Antioxid Redox Signal 7:823–828
15. Nakamura H, Nakamura K, Yodoi J (1997) Redox regulation of cellular activation. Annu Rev Immunol 15:351–369
16. Burke-Gaffney A, Callister ME, Nakamura H (2005) Thioredoxin: friend or foe in human disease? Trends Pharmacol Sci 26:398–404
17. Zhang XY, Chen DC, Xiu MH et al (2013) Thioredoxin, a novel oxidative stress marker and cognitive performance in chronic and medicated schizophrenia versus healthy controls. Schizophr Res 143(2):301–306
18. Al-Gayyar MMH, Abdelsaid MA, Matragoon S et al (2011) Thioredoxin interacting protein is a novel mediator of retinal inflammation and neurotoxicity. Br J Pharmacol 164(1):170–180
19. Griffiths HR, Bennett SJ, Olofsson P et al (2014) Thioredoxin as a putative biomarker and candidate target in age-related immune decline. Biochem Soc Trans 42(4):922–927
20. Hatano S (1976) Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 54:541–553
21. Adams HP, Bendixen BH, Kappelle LJ et al (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35–41
22. Bamford J, Sandercock P, Dennis M et al (1991) Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337:1521–1526
23. Brott T, Adams HP Jr, Olinger CP et al (1989) Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20:864–870
24. Sims JR, Gharai LR, Schaefer PW et al (2009) ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology 72:2104–2110
25. Polidori MC, Frei B, Cherubini A, Nelles G, Rordorf G, Keaney JF Jr, Schwamm L, Mecocci P, Koroshetz WJ, Beal MF (1998) Increased plasma levels of lipid hydroperoxides in patients with ischemic stroke. Free Radic Biol Med 25:561–567
26. Erecińska M, Silver IA (2001) Tissue oxygen tension and brain sensitivity to hypoxia. Respir Physiol 128(3):263–276
27. Şeneş M, Kazan N, Coşkun Ö et al (2007) Oxidative and nitrosative stress in acute ischaemic stroke. Ann Clin Biochem 44(1):43–47
28. Sánchez-Moreno C, Dashe JF, Scott T et al (2004) Decreased levels of plasma vitamin C and increased concentrations of inflammatory and oxidative stress markers after stroke. Stroke 35(1):163–168
29. El Kossi MMH, Zakhary MM (2000) Oxidative stress in the context of acute cerebrovascular stroke. Stroke 31(8):1889–1892
30. Polidori MC, Cherubini A, Stahl W, Senin U, Sies H, Mecocci P (2002) Plasma carotenoid and malondialdehyde levels in ischemic stroke patients: relationship to early outcome. Free Radic Res 36:265–268
31. Uno M, Kitazato KT, Nishi K, Itabe H, Nagahiro S (2003) Raised plasma oxidised LDL in acute cerebral infarction. J Neurol Neurosurg Psychiatry 74:312–316
32. Fam SS, Morrow JD (2003) The isoprostanes: unique products of arachidonic acid oxidation—a review. Curr Med Chem 10:1723–1740
33. Kelly PJ, Morrow JD, Ning MM et al (2008) Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study. Stroke 39(1):100–104
34. Ozkul A, Akyol A, Yenisey C et al (2007) Oxidative stress in acute ischemic stroke. J Clin Neurosci 14(11):1062–1066
35. Chen H, Yoshioka H, Kim GS et al (2011) Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection. Antioxid Redox Signal 14(8):1505–1517
36. Carbonell T, Rama R (2007) Iron, oxidative stress and early neurological deterioration in ischemic stroke. Curr Med Chem 14(8):857–874
37. Nanetti L, Raffaelli F, Vignini A et al (2011) Oxidative stress in ischaemic stroke. Eur J Clin Investig 41(12):1318–1322
38. Luna JM, Moon YP, Liu KM et al (2014) High-sensitivity C-reactive protein and interleukin-6-dominant inflammation and ischemic stroke risk: the northern Manhattan study. Stroke 45(4):979–987
39. Maurice MM, Nakamura H, Gringhuis S et al (1999) Expression of the thioredoxin–thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum 42:2430–2439
40. Ma YH, Su N, Chao XD et al (2012) Thioredoxin-1 attenuates post-ischemic neuronal apoptosis via reducing oxidative/nitrative stress. Neurochem Int 60(5):475–483
41. Ishrat T, Mohamed IN, Pillai B et al (2014) Thioredoxin-interacting protein: a novel target for neuroprotection in experimental thromboembolic stroke in mice. Mol Neurobiol. doi:10.1007/s12035-014-8766-x
42. Domínguez C, Delgado P, Vilches A et al (2010) Oxidative stress after thrombolysis-induced reperfusion in human stroke. Stroke 41(4):653–660
43. Emsley HC, Smith CJ, Gavin CM et al (2003) An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol 139(1–2):93–101
44. Saeed SA, Shad KF, Saleem T, Javed F, Khan MU (2007) Some new prospects in the understanding of the molecular basis of the pathogenesis of stroke. Exp Brain Res 182:1–10
45. Lipton SA (1999) Redox sensitivity of NMDA receptors. Methods Mol Biol 128:121–130
46. Chan PH (2005) Mitochondrial dysfunction and oxidative stress as determinants of cell death/survival in stroke. Ann NY Acad Sci 1042(1):203–209
47. Montecucco F, Lenglet S, Gayet-Ageron A et al (2010) Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic stroke. Stroke 41(7):1394–1404
48. Hattori I, Takagi Y, Nakamura H, Nozaki K, Bai J, Kondo N, Sugino T, Nishimura M, Hashimoto N, Yodoi J (2004) Intravenous administration of thioredoxin decreases brain damage following transient focal cerebral ischemia in mice. Antioxid Redox Signal 6:81–87